Clinical Trial Update: Efficacy of Ketamine in Children With Severe Brain Injury for Brain Cell Protection [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating ketamine for brain cell protection in children with severe traumatic brain injury was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: University of Arkansas | Conditions: Traumatic Brain Injury | Phase 2 | Status: WITHDRAWN